Document is current
Any future updates will be listed below
-
Authors
Chalancon, Benoit
Haesebaert, Julie
Vacher, Aurélie
Vieux, Maxime
Simon, Louis
Subtil, Fabien
Colin, Cyrille
Poulet, Emmanuel
Leaune, Edouard
,
Almeida, Sarah
Barasino, Olivia
Benoist, Marine
Boudin, Pauline
Bastard, Elodie
Bussière Lheureux, Marion
Dalmont, Julia
Denes, Damien
Dubois, Florence
Duchemin, Pierrick
Durand, Evan
Evo, Priscilla
Folin, Charlotte
Fouldrin, Gaël
Freton, Maxime
Gérard, Pierre
Gil, Alain
Guillemet-Senkel, Pauline
Hauray, Arthur
Heros, Julien
Lallement, Baptiste
Lefort, Clément
Le Gal, Dewi
Lelandais, Anne
Léger, Emmanuel
Leperchois, Romain
Marchand, Clémence
Mascarel, Pauline
Mugnier, Gabrielle
Paturaux, Claire
Petit, Jérôme
Roux, Paul
Ruttee, Fazna
Saludas, Carole
Supera, Mélodie
Terrolles, Brice
Touvenot, Audrey
Turpin, Maëva
Varin, Laure
Vandevelde, Anaïs
,
Chapelle, Rémy
Cléva, Elise
Damasceno, Caroline
Guyodo, Josselin
Leblanc, Judith
Nouvel, Erwann
Perot, Romain
Robic, Gilles
Vernet, Tamara
- License Information
-
More Information
Article History
Received: 17 January 2024
Accepted: 28 April 2025
First Online: 19 May 2025
Declarations
:
: The study, sponsored by the “Le Vinatier”, will be conducted in accordance with the recommendations provided in the current version of the Declaration of Helsinki. This study was approved by the ethics committee Comité de protection des personnes Sud Ouest et Outre mer 1- (registration number: 2022-A00163-40). The reference methodology MR001 (framework for the processing of health data in interventional research) will be respected in the implementation of the study. Information and written consent from the participant will be required by the professional. This consent will be archived for quality control purposes. An authorization from the Commission Nationale de l’Informatique et des Libertés (CNIL) has been obtained (number 923012v2 for the collection of nominative data and the telephone numbers of patients and persons contact. The data will be archived 15 years after the completion or interruption of the research. The study was preregistered at clinicaltrials.gov, first registered on 8 November 2022 ( registration number: NCT05609487). All important protocol modifications (e.g., changes to eligibility criteria, outcomes, analyses) will be communicated to relevant parties (coinvestigators, trial registries, regulators).
: Not applicable.
: The authors declare no competing interests.
